Published in BMC Cancer on January 24, 2009
Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. J Clin Invest (2011) 1.27
In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model. BMC Cancer (2011) 1.21
Evaluation of metastatic and angiogenic potentials of human colon carcinoma cells in chick embryo model systems. Clin Exp Metastasis (2009) 0.92
Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin. Int J Cancer (2011) 0.91
Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases. BMC Cancer (2010) 0.88
A novel llama antibody targeting Fn14 exhibits anti-metastatic activity in vivo. MAbs (2014) 0.84
Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization. Genes Dev (2016) 0.83
Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin. Neoplasia (2017) 0.75
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer. J Vis Exp (2016) 0.75
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med (2004) 49.02
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med (2004) 30.26
Systemic spread is an early step in breast cancer. Cancer Cell (2008) 7.91
Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs (1999) 4.32
In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases. Cancer Res (2006) 1.76
Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin Cancer Res (1998) 1.68
Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am J Pathol (2007) 1.44
Cancer dormancy: opportunities for new therapeutic approaches. Nat Med (1997) 1.31
Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer (2004) 1.28
Xenograft models for liver metastasis: Relationship between tumor morphology and adenovirus vector transduction. Mol Ther (2004) 1.22
Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J Clin Oncol (1996) 1.22
Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis. World J Surg (2006) 1.11
Significance of micrometastases in colorectal cancer. Ann Surg Oncol (2002) 1.05
Development and characterization of a model of liver metastasis using human colon cancer HCT-116 cells. Biol Pharm Bull (2007) 1.05
Experimental liver metastasis: standards for local cell implantation to study isolated tumor growth in mice. Clin Exp Metastasis (2004) 1.00
Surgical resection of liver metastases of colorectal carcinoma: short and long-term results. Semin Oncol (2000) 0.96
Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis. Scand J Gastroenterol (2005) 0.91
Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer. Ann Surg (1997) 0.91
Human tumour xenografts in athymic rats and their age dependence. Br J Cancer (1982) 0.91
Optimization of a metastasizing human gastric cancer model in nude mice. Microsurgery (2003) 0.91
Feasibility and limits of an orthotopic human colon cancer model in nude mice. Comp Med (2006) 0.84
Human antibody SC-1 reduces disseminated tumor cells in nude mice with human gastric cancer. Oncol Rep (2005) 0.83
Site-directed metastasis: a model to study site variations in treatment response. J Surg Res (1988) 0.77
Identification of cells initiating human melanomas. Nature (2008) 8.28
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res (2005) 3.52
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut (2011) 3.42
Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression. Cancer Lett (2012) 2.05
Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis (2012) 1.62
VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res (2011) 1.62
Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months. Pain (2013) 1.52
Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg (2013) 1.47
Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol (2011) 1.44
Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest (2005) 1.38
Intimal angiosarcoma of the aorta: report of a case and review of the literature. J Vasc Surg (2004) 1.35
Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg (2010) 1.32
ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients. Cancer Res (2011) 1.23
Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology (2011) 1.23
Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer (2008) 1.23
Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer. PLoS One (2013) 1.13
Isolation of tumorigenic circulating melanoma cells. Biochem Biophys Res Commun (2010) 1.13
A prospective randomized study to test the transfer of basic psychomotor skills from virtual reality to physical reality in a comparable training setting. Ann Surg (2005) 1.11
CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1. J Biol Chem (2010) 1.11
Morbidity of temporary loop ileostomy in patients with colorectal cancer. Dis Colon Rectum (2006) 1.10
The mutagenic potential of duodenoesophageal reflux. Ann Surg (2005) 1.08
Changes in depression following gastric banding: a 5- to 7-year prospective study. Obes Surg (2008) 1.07
Heme oxygenase-1 promotes survival of renal cancer cells through modulation of apoptosis- and autophagy-regulating molecules. J Biol Chem (2012) 1.05
Roux-en-Y gastric bypass surgery reduces bone mineral density and induces metabolic acidosis in rats. Am J Physiol Regul Integr Comp Physiol (2013) 1.04
The heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-apoptotic signal. J Biol Chem (2011) 1.02
Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis. Nutr Cancer (2004) 1.00
Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents. Front Microbiol (2011) 1.00
Who benefits from gastric banding? Obes Surg (2007) 0.99
Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats. PLoS One (2013) 0.99
Increased postprandial energy expenditure may explain superior long term weight loss after Roux-en-Y gastric bypass compared to vertical banded gastroplasty. PLoS One (2013) 0.97
Band erosion and passage, causing small bowel obstruction. Obes Surg (2006) 0.95
Cardiorespiratory fitness and insulin sensitivity in overweight or obese subjects may be linked through intrahepatic lipid content. Diabetes (2010) 0.95
Estradiol increases body weight loss and gut-peptide satiation after Roux-en-Y gastric bypass in ovariectomized rats. Gastroenterology (2012) 0.94
Short- and long-term results of laparoscopic gastric banding for morbid obesity. Langenbecks Arch Surg (2007) 0.94
LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's esophagus? J Exp Clin Cancer Res (2011) 0.93
Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression. Eur J Cancer (2010) 0.93
Ischemia-reperfusion injury-induced pulmonary mitochondrial damage. J Heart Lung Transplant (2011) 0.92
Donor antigen-specific regulatory T-cell function affects outcome in kidney transplant recipients. Kidney Int (2011) 0.92
Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis. Scand J Gastroenterol (2005) 0.91
CIP2A influences survival in colon cancer and is critical for maintaining Myc expression. PLoS One (2013) 0.91
Optimization of a metastasizing human gastric cancer model in nude mice. Microsurgery (2003) 0.91
Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients. Hum Antibodies (2002) 0.89
Effect of bypassing the proximal gut on gut hormones involved with glycemic control and weight loss. Surg Obes Relat Dis (2012) 0.89
Reoperations after gastric banding: replacement or alternative procedures? Surg Endosc (2008) 0.88
Lessons learned from gastric bypass operations in rats. Obes Facts (2011) 0.88
Roux-en-Y gastric bypass surgery in rats alters gut microbiota profile along the intestine. Physiol Behav (2013) 0.88
Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases. BMC Cancer (2010) 0.88
Regulatory functions of alloreactive Th2 clones in human renal transplant recipients. Kidney Int (2002) 0.88
Effects of preoperative exposure to a high-fat versus a low-fat diet on ingestive behavior after gastric bypass surgery in rats. Surg Endosc (2013) 0.87
Constitutive JNK activation in NIH 3T3 fibroblasts induces a partially transformed phenotype. J Biol Chem (2002) 0.87
Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress. BMC Complement Altern Med (2012) 0.87
Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass. Physiol Behav (2013) 0.87
Gastric leakage after sleeve gastrectomy-clinical presentation and therapeutic options. Langenbecks Arch Surg (2011) 0.87
A novel in vivo regulatory role of P-glycoprotein in alloimmunity. Biochem Biophys Res Commun (2010) 0.86
The impact of reflux composition on mucosal injury and esophageal function. J Gastrointest Surg (2006) 0.86
Tumor induction by activated JNK occurs through deregulation of cellular growth. Cancer Lett (2004) 0.85
The Bariatric Quality of Life index: a measure of well-being in obesity surgery patients. Obes Surg (2005) 0.84
Detection of disseminated tumor cells in nude mice with human gastric cancer. Clin Exp Metastasis (2003) 0.84
A novel llama antibody targeting Fn14 exhibits anti-metastatic activity in vivo. MAbs (2014) 0.84
Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer. Eur J Cancer (2010) 0.84
Feasibility and limits of an orthotopic human colon cancer model in nude mice. Comp Med (2006) 0.84
Human antibody SC-1 reduces disseminated tumor cells in nude mice with human gastric cancer. Oncol Rep (2005) 0.83
K-ras mutations and cetuximab in colorectal cancer. N Engl J Med (2009) 0.83
Physiological mechanisms behind Roux-en-Y gastric bypass surgery. Dig Surg (2014) 0.83
Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. J Am Soc Nephrol (2002) 0.83
Short-term immunosuppression after rat parathyroid allotransplantation. Microsurgery (2003) 0.83
MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status. J Transl Med (2010) 0.82
Predictability of outcome in laparoscopic gastric banding. Obes Facts (2009) 0.82
T-cell response to p53 tumor-associated antigen in patients with colorectal carcinoma. Int J Oncol (2006) 0.82
Glutathione preconditioning ameliorates mitochondria dysfunction during warm pulmonary ischemia-reperfusion injury. Eur J Cardiothorac Surg (2012) 0.82
Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients. BMC Cancer (2015) 0.81
Noninvasive visualization of tumor growth in a human colorectal liver metastases xenograft model using bioluminescence in vivo imaging. J Surg Res (2013) 0.81
The concurrence of histologically positive resection margins and sessile morphology is an important risk factor for lymph node metastasis after complete endoscopic removal of malignant colorectal polyps. Int J Colorectal Dis (2009) 0.81
The role of FOXP3 in disease progression in colorectal cancer patients. Oncoimmunology (2013) 0.81
Mechanisms of tolerance induction after rat liver transplantation: intrahepatic CD4(+) T cells produce different cytokines during rejection and tolerance in response to stimulation. J Gastrointest Surg (2002) 0.80
Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822Y. Am J Surg Pathol (2008) 0.80
Neoadjuvant therapy of gastric cancer with the human monoclonal IgM antibody SC-1: impact on the immune system. Oncol Rep (2008) 0.80
Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages. Transpl Immunol (2009) 0.80